Global Biosafety Testing Market Research Report 2024

Publication ID:

PB505242763

Publication Date:

May 27, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Biosafety Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Biosafety Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biosafety Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biosafety Testing in Vaccine is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biosafety Testing include Merck, Charles River, Sartorius, Samsung Biologics, GenomeScan, Creative Biogene, Eurofins Scientific, Wuxi Biologics and Creative BioMart, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biosafety Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosafety Testing.
Report Scope
The Biosafety Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biosafety Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosafety Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Charles River
Sartorius
Samsung Biologics
GenomeScan
Creative Biogene
Eurofins Scientific
Wuxi Biologics
Creative BioMart
SGS Group
Segment by Type
Cell Line Characterization
Lot Release Testing
Viral Clearance
Others
Segment by Application
Vaccine
Monoclonal Antibodies
Cell Therapy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosafety Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosafety Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cell Line Characterization
1.2.3 Lot Release Testing
1.2.4 Viral Clearance
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biosafety Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Vaccine
1.3.3 Monoclonal Antibodies
1.3.4 Cell Therapy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosafety Testing Market Perspective (2019-2030)
2.2 Biosafety Testing Growth Trends by Region
2.2.1 Global Biosafety Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biosafety Testing Historic Market Size by Region (2019-2024)
2.2.3 Biosafety Testing Forecasted Market Size by Region (2025-2030)
2.3 Biosafety Testing Market Dynamics
2.3.1 Biosafety Testing Industry Trends
2.3.2 Biosafety Testing Market Drivers
2.3.3 Biosafety Testing Market Challenges
2.3.4 Biosafety Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosafety Testing Players by Revenue
3.1.1 Global Top Biosafety Testing Players by Revenue (2019-2024)
3.1.2 Global Biosafety Testing Revenue Market Share by Players (2019-2024)
3.2 Global Biosafety Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biosafety Testing Revenue
3.4 Global Biosafety Testing Market Concentration Ratio
3.4.1 Global Biosafety Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosafety Testing Revenue in 2023
3.5 Biosafety Testing Key Players Head office and Area Served
3.6 Key Players Biosafety Testing Product Solution and Service
3.7 Date of Enter into Biosafety Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosafety Testing Breakdown Data by Type
4.1 Global Biosafety Testing Historic Market Size by Type (2019-2024)
4.2 Global Biosafety Testing Forecasted Market Size by Type (2025-2030)
5 Biosafety Testing Breakdown Data by Application
5.1 Global Biosafety Testing Historic Market Size by Application (2019-2024)
5.2 Global Biosafety Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biosafety Testing Market Size (2019-2030)
6.2 North America Biosafety Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biosafety Testing Market Size by Country (2019-2024)
6.4 North America Biosafety Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosafety Testing Market Size (2019-2030)
7.2 Europe Biosafety Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biosafety Testing Market Size by Country (2019-2024)
7.4 Europe Biosafety Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosafety Testing Market Size (2019-2030)
8.2 Asia-Pacific Biosafety Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biosafety Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Biosafety Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosafety Testing Market Size (2019-2030)
9.2 Latin America Biosafety Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biosafety Testing Market Size by Country (2019-2024)
9.4 Latin America Biosafety Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosafety Testing Market Size (2019-2030)
10.2 Middle East & Africa Biosafety Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biosafety Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Biosafety Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Biosafety Testing Introduction
11.1.4 Merck Revenue in Biosafety Testing Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Charles River
11.2.1 Charles River Company Detail
11.2.2 Charles River Business Overview
11.2.3 Charles River Biosafety Testing Introduction
11.2.4 Charles River Revenue in Biosafety Testing Business (2019-2024)
11.2.5 Charles River Recent Development
11.3 Sartorius
11.3.1 Sartorius Company Detail
11.3.2 Sartorius Business Overview
11.3.3 Sartorius Biosafety Testing Introduction
11.3.4 Sartorius Revenue in Biosafety Testing Business (2019-2024)
11.3.5 Sartorius Recent Development
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Detail
11.4.2 Samsung Biologics Business Overview
11.4.3 Samsung Biologics Biosafety Testing Introduction
11.4.4 Samsung Biologics Revenue in Biosafety Testing Business (2019-2024)
11.4.5 Samsung Biologics Recent Development
11.5 GenomeScan
11.5.1 GenomeScan Company Detail
11.5.2 GenomeScan Business Overview
11.5.3 GenomeScan Biosafety Testing Introduction
11.5.4 GenomeScan Revenue in Biosafety Testing Business (2019-2024)
11.5.5 GenomeScan Recent Development
11.6 Creative Biogene
11.6.1 Creative Biogene Company Detail
11.6.2 Creative Biogene Business Overview
11.6.3 Creative Biogene Biosafety Testing Introduction
11.6.4 Creative Biogene Revenue in Biosafety Testing Business (2019-2024)
11.6.5 Creative Biogene Recent Development
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Company Detail
11.7.2 Eurofins Scientific Business Overview
11.7.3 Eurofins Scientific Biosafety Testing Introduction
11.7.4 Eurofins Scientific Revenue in Biosafety Testing Business (2019-2024)
11.7.5 Eurofins Scientific Recent Development
11.8 Wuxi Biologics
11.8.1 Wuxi Biologics Company Detail
11.8.2 Wuxi Biologics Business Overview
11.8.3 Wuxi Biologics Biosafety Testing Introduction
11.8.4 Wuxi Biologics Revenue in Biosafety Testing Business (2019-2024)
11.8.5 Wuxi Biologics Recent Development
11.9 Creative BioMart
11.9.1 Creative BioMart Company Detail
11.9.2 Creative BioMart Business Overview
11.9.3 Creative BioMart Biosafety Testing Introduction
11.9.4 Creative BioMart Revenue in Biosafety Testing Business (2019-2024)
11.9.5 Creative BioMart Recent Development
11.10 SGS Group
11.10.1 SGS Group Company Detail
11.10.2 SGS Group Business Overview
11.10.3 SGS Group Biosafety Testing Introduction
11.10.4 SGS Group Revenue in Biosafety Testing Business (2019-2024)
11.10.5 SGS Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Merck
Charles River
Sartorius
Samsung Biologics
GenomeScan
Creative Biogene
Eurofins Scientific
Wuxi Biologics
Creative BioMart
SGS Group

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂